Juvéderm Ultrasmile
Juvéderm Ultrasmile is utilized to enhance the shape of the lips, diminish wrinkles around the mouth, and provide more fullness and volume to the lips.
The lips play a significant role in facial expression, contributing to overall facial appearance. While the perception of beautiful lips may seem subjective, scientific studies have identified common features associated with “beautiful lips”: natural-looking fullness, well-defined contours, and a soft, gentle appearance.
Juvéderm Ultrasmile is employed in various ways to achieve natural and aesthetically pleasing results:
– Filling both upper and lower lips with Juvéderm ULTRA SMILE enhances natural fullness and achieves a balanced ratio between the two – a common desire among women.
– Treating lip contours with Juvéderm ULTRA SMILE creates clear, well-defined lip shapes with improved and more pronounced contours.
– Juvéderm ULTRA SMILE enhances the appearance and suppleness of the lips, fulfilling the desire for soft and naturally beautiful lips.
– Filling vertical lines and the area above the lips, often caused by smoking and puckering, with Juvéderm ULTRA SMILE results in a smoother and fresher appearance around the mouth.
Specifically recommended for natural and gentle lip enhancement, Juvéderm ULTRA SMILE contains a local anesthetic for a comfortable treatment experience.
Details about Juvéderm Ultra Smile prefilled syringe:
– Manufacturer: Pharm-Allergan GmbH
– Product line: Juvéderm
– Dosage form: Prefilled syringe
– Application: Only by medical professionals (doctor or dentist)
– Contents: 2 prefilled syringes of 0.55 ml each, 2 cannulas 30G ½”
– Contains biosynthetically produced hyaluronic acid
– Active ingredients:
– Hyaluronic acid, 24 mg/ml
– 0.3% lidocaine hydrochloride
Note: According to Section 3 Number 17 of the Medical Devices Act, medical devices such as Juvéderm Ultrasmile not intended for laypersons may only be obtained by trained professionals, unless a medical or dental prescription is provided.
Reviews
There are no reviews yet.